Spero Therapeutics Inc. (SPRO)
NASDAQ · Healthcare
Spero Therapeutics Inc. Revenue 2016–2025
Spero Therapeutics Inc. annual/quarterly revenue history and growth rate from 2016 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Spero Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 0, a 100.00% decrease year-over-year.
- Spero Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 12000, a 97.77% decrease year-over-year.
- Spero Therapeutics Inc. annual revenue for 2025 was 12.6 M, a 3292.45% increase from 2024.
- Spero Therapeutics Inc. annual revenue for 2024 was 371000, a 60.24% decrease from 2023.
- Spero Therapeutics Inc. annual revenue for 2023 was 933000, a 62.72% decrease from 2022.
- Spero Therapeutics Inc. annual revenue for 2022 was 2.5 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Spero Therapeutics Inc. Revenue — FAQ
Spero Therapeutics Inc. (SPRO) revenue over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
What is Spero Therapeutics Inc.'s revenue?
Spero Therapeutics Inc. (SPRO) reported revenue of $13M for fiscal 2025.
Where can I see SPRO's revenue history?
The chart and table above show Spero Therapeutics Inc.'s revenue by year and by quarter, including the growth rate.